Staphylococcus Aureus Bacteremia Due to Central Venous Catheter Infection: A Clinical Comparison of Infections Caused by Methicillin-Resistant and Methicillin-Susceptible Strains
暂无分享,去创建一个
[1] K. McConeghy,et al. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] C. Diazgranados,et al. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[3] M. Bassetti,et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] S. Choi,et al. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia , 2011, Intensive Care Medicine.
[6] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] K. Stellrecht,et al. Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin , 2008, Antimicrobial Agents and Chemotherapy.
[8] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[9] Á. Soriano,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] M. Zhan,et al. Comparison of Mortality Risk Associated With Bacteremia Due to Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus , 2007, Infection Control & Hospital Epidemiology.
[11] H. Ikeuchi,et al. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[12] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.